<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04670900</url>
  </required_header>
  <id_info>
    <org_study_id>REC2018/88</org_study_id>
    <nct_id>NCT04670900</nct_id>
  </id_info>
  <brief_title>Treatment of Olecranon Fractures in the Elderly</brief_title>
  <acronym>CROFT2</acronym>
  <official_title>Operative or Non-Operative Treatment of Displaced Fractures of the Elderly - A Nordic Multicenter Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Operative treatment, with tension band wiring or plate fixation, will be compared with&#xD;
      non-operative treatment of displaced olecranon fractures (Mayo classification 2A and 2B) in&#xD;
      patients 75 years or older.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Displaced olecranon fractures disrupt the extensor mechanism of the elbow and operative&#xD;
      treatment is therefore usually recommended. Tension band wiring (TBW) and plate fixation (PF)&#xD;
      are the most common surgical treatment options. Both methods are associated with high&#xD;
      complication and reoperation rates, especially in elderly patients. Only one randomized&#xD;
      controlled trial has compared operative and non-operative treatment of olecranon fractures in&#xD;
      the elderly, but the study was stopped prematurely due to high complication rates in the&#xD;
      group treated operatively and remained underpowered for important outcome measures.A few&#xD;
      small patient series with non-operatively treated fractures also exist and suggest that it&#xD;
      may be a valid alternative to operative treatment&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 22, 2021</start_date>
  <completion_date type="Anticipated">January 2024</completion_date>
  <primary_completion_date type="Anticipated">January 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized non-inferiority multicenter</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Patient instructed not to reveal treatment and to wear long sleeves.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Oxford Elbow Score</measure>
    <time_frame>52 weeks</time_frame>
    <description>Patient reported 12 item form, 0 (worst) to 100 (best possible score)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Range of motion</measure>
    <time_frame>6 weeks</time_frame>
    <description>Extension, flexion, rotation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of motion</measure>
    <time_frame>12 weeks</time_frame>
    <description>Extension, flexion, rotation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of motion</measure>
    <time_frame>52 weeks</time_frame>
    <description>Extension, flexion, rotation measured in degrees total movement for each direction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Elbow extension strength</measure>
    <time_frame>6 weeks</time_frame>
    <description>Strength measured isometrically on a scale (grams) with elbow in 30 degrees flexion. Both arms measured for comparison.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Elbow extension strength</measure>
    <time_frame>12 weeks</time_frame>
    <description>Strength measured isometrically on a scale (grams) with elbow 30 degrees flexion. Both arms measured for comparison.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Elbow extension strength</measure>
    <time_frame>52 weeks</time_frame>
    <description>Strength measured isometrically on a scale (grams) with elbow 30 degrees flexion. Both arms measured for comparison. arms measured for comparison.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Elbow satisfaction</measure>
    <time_frame>6 weeks</time_frame>
    <description>Single question: Are you satisfied with your elbow? Yes/Somewhat/No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Elbow satisfaction</measure>
    <time_frame>12 weeks</time_frame>
    <description>Single question: Are you satisfied with your elbow? Yes/Somewhat/No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Elbow satisfaction</measure>
    <time_frame>52 weeks</time_frame>
    <description>Single question: Are you satisfied with your elbow? Yes/Somewhat/No</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>Through study period up to 52 weeks.</time_frame>
    <description>Serious local complications not reoperated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Reoperations</measure>
    <time_frame>Through study period up to 52 weeks.</time_frame>
    <description>Any reoperation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxford Elbow Score</measure>
    <time_frame>6 weeks</time_frame>
    <description>Patient reported 12 item form, 0 (worst) to 100 (best possible score)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxford Elbow Score</measure>
    <time_frame>12 weeks</time_frame>
    <description>Patient reported 12 item form, 0 (worst) to 100 (best possible score)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Olecranon Fracture</condition>
  <arm_group>
    <arm_group_label>Operative</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be operated according to Orthopedic Trauma Association (OTA) principles with either tension band wiring or plate fixation with an anatomical precontoured plate.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-operative</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be offered a plaster cast for 1-2 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tension band wiring or plate fixation</intervention_name>
    <description>Choice of operative treatment is TBW or PF with a precontoured anatomical plate. The treating surgeon decides if TBW or PF is chosen as operative treatment method. The surgeries are performed according to OTA principles by an experienced surgeon, a trauma fellow or a consultant as approved by the participating hospitals.</description>
    <arm_group_label>Operative</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Active non-operative treatment with optional plaster cast</intervention_name>
    <description>Patients allocated to non-operative treatment are offered a back-slab in 60 degrees of flexion for pain-relief. The back-slab is removed 7-14 days following injury.</description>
    <arm_group_label>Non-operative</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Displaced olecranon fracture (Mayo 2A and 2B).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Associated fractures in the coronoid process, radial head or distal humerus.&#xD;
&#xD;
          -  Open fracture, Gustilo-Andersen 2 or 3&#xD;
&#xD;
          -  Severe cardiopulmonary disease or other medical condition which contraindicates&#xD;
             surgery.&#xD;
&#xD;
          -  Previous injury to or other condition in the elbow with serious functional impairment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>75 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frede Frihagen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oslo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Frede Frihagen, PhD</last_name>
    <phone>+4791332738</phone>
    <email>ffrihagen@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kaare S Midtgaard, MD</last_name>
    <phone>+4793412696</phone>
    <email>Kaare.midtgaard@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Baerum Hospital</name>
      <address>
        <city>Sandvika</city>
        <state>Gjettum</state>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ellen Langslet, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Espen Laudal</last_name>
      <email>ESLAUD@vestreviken.no</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St. Olavs Hospital</name>
      <address>
        <city>Trondheim</city>
        <state>Trønderlag</state>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Gunnar Johnsen, PhD</last_name>
      <email>lars.gunnar.johnsen@ntnu.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Arendal Hospital</name>
      <address>
        <city>Arendal</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Knut Erik Mjaaland, PhD</last_name>
      <email>Knut.Erik.Mjaaland@sshf.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Haukeland University Hospital</name>
      <address>
        <city>Bergen</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jostein Skorpa Nilsen, MD</last_name>
      <email>j.skorpa@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Østfold Hospital Trust</name>
      <address>
        <city>Grålum</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frede Frihagen, PhD</last_name>
      <phone>+4791332738</phone>
      <email>ffrihagen@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vestre Viken Hospital Trust</name>
      <address>
        <city>Hønefoss</city>
        <zip>3511</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Audun Tangerud, MD</last_name>
      <phone>+4732803000</phone>
      <email>audun.tangerud@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Orthopedic Center, Ulleval University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0408</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Diakonhjemmet Hospital</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marius Coucheron, MD</last_name>
      <phone>+4799298431</phone>
      <email>Marius.Coucheron@diakonsyk.no</email>
    </contact>
    <contact_backup>
      <last_name>Bugge</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Telemark Hospital</name>
      <address>
        <city>Skien</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hilde Apold, PhD</last_name>
      <email>hildeapold@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stavanger University Hospital</name>
      <address>
        <city>Stavanger</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ane Djuv, PhD</last_name>
      <email>ane.djuv@sus.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tønsberg Hospital</name>
      <address>
        <city>Tønsberg</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tor Nicolaysen, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Akademiska Hospital</name>
      <address>
        <city>Uppsala</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Greta Snellman, MD</last_name>
      <email>greta.snellman@surgsci.uu.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Savvidou OD, Koutsouradis P, Kaspiris A, Naar L, Chloros GD, Papagelopoulos PJ. Displaced olecranon fractures in the elderly: outcomes after non-operative treatment - a narrative review. EFORT Open Rev. 2020 Aug 1;5(7):391-397. doi: 10.1302/2058-5241.5.190041. eCollection 2020 Jul. Review.</citation>
    <PMID>32818066</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>December 8, 2020</study_first_submitted>
  <study_first_submitted_qc>December 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>May 10, 2021</last_update_submitted>
  <last_update_submitted_qc>May 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Frede Frihagen</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Elderly patients</keyword>
  <keyword>Surgery</keyword>
  <keyword>Non-operative treatment</keyword>
  <keyword>Functional outcome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Publish protocol</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Within 12 months</ipd_time_frame>
    <ipd_access_criteria>Open access</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

